莱博雷生在中国上市了吗？好购买吗？

Introduction: Lebrasin is an innovative insomnia treatment drug. Its launch in the Chinese market, convenience of purchase, and considerations of medication for special groups are topics of concern to many patients and medical professionals. This article will introduce these issues in detail.

Is Lebrasen available in China?

It has not yet been officially launched in mainland China, but the Center for Drug Evaluation (CDE) of the State Food and Drug Administration of China has accepted Eisai’s marketing application for Lebrasen tablets filed under registration classification 5.1, which means Lebrasen is expected to be approved and marketed in the Chinese market. The specific launch time needs to be determined based on the review progress and market conditions. Prior to this, patients could not directly purchase Lebraxen through formal channels in the country.

Marketing status in Hong Kong, China

Lebrasin has been approved for marketing in Hong Kong, China, for the treatment of adult insomnia, especially difficulty falling asleep and/or maintaining sleep. This provides an avenue for patients in need to purchase, albeit across borders.

International marketing status

Since Lebraxant was approved for marketing by the U.S. Food and Drug Administration (FDA) on December 20, 2019, it has been successfully launched in many countries and regions, including the United States, Japan, Canada, and Australia. These listing experiences in international markets provide valuable reference for Lebrasin’s listing in the Chinese market.

Is Lebrasant easy to buy?

Since Lebrasant has not yet been launched in China, patients cannot purchase the drug directly through hospitals or pharmacies. However, for patients who urgently need leborexan, there are still some purchase options available, but they need to pay attention to legality and safety.

Medical service institutions

Patients can purchase through medical service institutions, which usually provide original and authentic products, but patients need to carefully check the drug information, including drug name, specifications, manufacturer, approval number, etc., to ensure that they are purchasing legal and compliant drugs.

Hospitals or pharmacies

Patients can also go to countries or regions where Lebrasin is listed and purchase the drug at local hospital pharmacies or physical pharmacies. Before purchasing the drug, they need to present a medical prescription and use the drug under the guidance of a doctor.

Leborexant’s use in special populations

As a new type of drug, Leborexen’s use in special populations is particularly important. The following are things that some special groups need to pay attention to when using Lebraxen:

Elderly people

The elderly should be alert to the risk of falls when using Lebraxen, especially when the dose exceeds 5 mg. Due to the decline in physical functions of the elderly, the sensitivity to drugs may increase, so special caution is required when using them.

Patients with liver and renal impairment

When patients with liver and renal impairment take leborexan, the dose may need to be adjusted according to their condition. Patients with renal impairment may be at increased risk of drowsiness, but dose adjustment is generally not required; while patients with severe hepatic impairment are not recommended to use leboresen.

Persons with impaired respiratory function

Patients with impaired respiratory function should consider the potential respiratory effects when using Lebrasen. Because leborexan may affect the function of the respiratory center, adequate evaluation is required before use.

Before purchasing and using Lepore, patients should consult a professional doctor or pharmacist to learn about the drug’s indications, usage and dosage, adverse reactions, precautions and other information. Doctors' professional guidance helps patients use medications correctly and avoid potential risks.